MedTrace Logo

Antiretroviral Treatment Outcomes in HIV-HBV Co-infected Patients in Southern Africa

NCT02060162 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 897

Last updated 2021-11-12

No results posted yet for this study

Summary

This is a prospective HIV cohort that aims to establish causes of liver disease among HIV-infected individuals in Zambia, including viral hepatitis and alcohol.

Conditions

Interventions

OTHER

Standard of care

routine standard of care per Ministry of Health protocol including blood draws and examinations.

Sponsors & Collaborators

  • Centre for Infectious Disease Research in Zambia

    collaborator OTHER

  • University of Bern

    collaborator OTHER

  • University of Alabama at Birmingham

    lead OTHER

Principal Investigators

  • Roma Chilengi, MD · Centre for Infectious Disease Research in Zambia

  • Michael Vinikoor, MD · Centre for Infectious Disease Research in Zambia

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2021-01-01
Completion
2021-01-01

Countries

  • Zambia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02060162 on ClinicalTrials.gov